Trademark

FED BIO Trademark Information

Number:
2646011
Words:
FED BIO
Kind:
Word
Status group:
PENDING
Status code:
Accepted
Status detail:
Awaiting publication
Priority date:
28 Apr 2026
Lodgement date:
28 Apr 2026
First report date:
12 May 2026
Acceptance date:
12 May 2026
Filing date:
28 Apr 2026
Indexing constituents:
FED, BIO
Class:
1,5,40,42
Mark categories:
Trademark
Last status check:
2026-07-10 01:15:35
Status updated at:
2026-06-20 02:28:38
Goods and services:
1) Class: 1
Description: active chemical agents for the manufacture of pharmaceuticals, active chemical ingredients, active chemical ingredients for use in the manufacture of cosmetic products, active chemical ingredients for use in the manufacture of personal care products, active chemical ingredients for use in the manufacture of pharmaceuticals, antibodies for use in the manufacture of active ingredients of pharmaceuticals, antibodies for use in the manufacture of active ingredients of vaccines, antibody reagents for scientific purposes, biological preparations for use in biotechnology, other than for medical use, biological preparations for use in cell cultures, other than for medical purposes, cell culture media for laboratory use, cell culture media for scientific or research purposes, cell culture media for use in the biotechnological industry, cell culture reagents for scientific or research purposes, cell growth media for growing cells for use in scientific research, chemical additives for use in the manufacture of medicines, chemical additives for use in the manufacture of pharmaceuticals, chemical preparations for use in the manufacture of pharmaceuticals, chemical preparations for use in the production of medicines, chemical products for manufacturing medical preparations, chemicals for use in biotechnological manufacturing processes, monoclonal antibodies for in vitro scientific or research purposes, monoclonal antibodies for in vitro scientific research, monoclonal antibodies for scientific purposes, monoclonal antibodies for scientific use, reagents for the development of monoclonal antibodies for research purposes, reagents for the development of monoclonal antibodies for scientific purposes
2) Class: 5
Description: anti-viral vaccines, antibacterial vaccines, antibodies for medical purposes, antivirals, biochemical drugs, biochemical preparations for medical use, biological preparations for use in cell cultures for medical purposes, biopharmaceuticals for the treatment of cancer, biotechnological preparations for medical purposes, biotechnological preparations for medical use, cell culture media for medical purposes, cell growth media for growing cells for medical purposes, chemical preparations for therapeutical purposes, chemical preparations for therapeutical use, chemical products for pharmaceutical purposes, chemical products for therapeutical purposes, chemical products for therapeutical use, drugs for medical purposes, drugs for medical use, immunological antibodies for medical purposes, immunological antibodies for medical use, medicinal preparations and substances, medicinal preparations for the treatment of infectious diseases, medicinal preparations for use in oncology, medicines, medicines for human purposes, medicines for human use, pharmaceutical drugs, pharmaceutical preparations containing active chemical ingredients, pharmaceutical preparations containing amino acids, pharmaceutical preparations for health care, pharmaceutical preparations for the treatment of various diseases, pharmaceutical products and preparations, pharmaceutical products for use by humans, pharmaceutical substances, pharmaceuticals, reagents for the development of monoclonal antibodies for medical purposes, therapeutic drugs and agents, vaccine preparations, vaccines
3) Class: 40
Description: biomanufacturing of pharmaceuticals for others using biological organisms in the manufacturing process, custom biomanufacturing of cultured cell tissues, custom biomanufacturing of cultured cells, custom biomanufacturing of cultured ex vivo cell lines, custom biomanufacturing of pharmaceutical preparations, custom biomanufacturing of pharmaceutical products, custom biomanufacturing of pharmaceuticals, custom biomanufacturing of vaccines for preventing infectious diseases, custom biomanufacturing of vaccines for treating infectious diseases, custom manufacturing of RNA molecules for use in antibodies, custom manufacturing of antibody-drug conjugates, custom manufacturing of biomedical preparations, custom manufacturing of biopharmaceuticals, custom manufacturing of mRNA for use in antibodies, custom manufacturing of pharmaceutical preparations, custom manufacturing of pharmaceuticals, treatment of chemicals
4) Class: 42
Description: biochemical research and development, biomedical research, biotechnological research, biotechnology development, biotechnology research, cell culture services for scientific and research purposes for others, cell culturing for scientific research purposes, clinical research, consultancy in the field of pharmaceutical research, consultancy relating to research and development in the field of therapeutics, consulting services in the field of biotechnology, design and development of new products, development of new products, development of pharmaceutical preparations and medicines, development of pharmaceuticals, development of products for others in the field of pharmaceuticals, drug development, laboratory services for biomanufacturing, laboratory services for the production of pharmaceuticals, laboratory services for the production of vaccines, medical research, medical research and development, pharmaceutical drug development services, pharmaceutical research, pharmaceutical research and development, pharmaceutical testing, product development consultancy for inventors in the field of cellular biology, product development consultancy for inventors in the field of medicine, providing information about medical and scientific research in the field of pharmaceuticals, providing information and data relating to scientific and technological research and development, providing scientific research information in the field of pharmaceuticals, research and development for the pharmaceutical industry, research and development in the field of biomedicine, research and development in the field of microorganisms and cells, research and development in the field of pharmaceuticals, research and development of antibodies, research and development of chemical reagent antibodies and conjugate antibodies, research and development of conjugated antibodies, research and development of medicines, research and development of new products in the field of pharmaceuticals, research and development of vaccines, research and development of vaccines and medicines, research and development services in the field of antibodies, research and development services in the field of antibody technology, research and development services of new pharmaceutical products, research in the field of immunotolerance, research services in the field of proteins, antibodies, microorganisms and cells, research to develop new products, scientific and industrial research, scientific and medical research and development, scientific research, scientific research and development, scientific research for medical purposes, scientific research in the field of biotechnology, scientific research relating to chemistry, technical research, technical research in the field of pharmaceutical studies, technical testing services
History and publication details:
1) Date: 2026-05-12
Display name: Early Acceptance Notice correspondence sent
2) Date: 2026-05-12
Display name: Status change to Accepted
3) Date: 2026-04-28
Display name: IP Right Filed correspondence sent
4) Date: 2026-04-28
Display name: Examination expedited
5) Date: 2026-04-28
Display name: Awaiting examination
6) Date: 2026-04-28
Display name: IP Right Filed Published
7) Date: 2026-04-28
Display name: Status change to Published
8) Date: 2026-04-28
Display name: Status change to Filed
9) Date: 2026-04-28
Display name: Application Received
10) Date: 2026-04-28
Display name: Trade mark representation updated

Owner Information
Owner Acn:
696683440

Owner structured address:
6 Ralph Street, Alexandria, NSW, AUSTRALIA, Postal Code: 2015

Owner is private:
0

Service Information
Address Abn:
50167804088

Address Acn:
167804088

Address structured address:
Level 7 241 Commonwealth Street, Surry Hills, NSW, AUSTRALIA, Postal Code: 2010

Address is private:
0
Scroll to Top